Vaping Research Study

Researchers at Yale and MUSC are conducting a study to see if varenicline, a medication approved to help people quit smoking, can also help people cut down or quit vaping, and to look at how this may affect their health.

Fast Facts

Ages 18+ & Currently Vape/Use E-Cigarettes With Nicotine

Willing To Quit Vaping

Compensation

Provided

Conducted in Connecticut and South Carolina

Study Background

Can a Quit-Smoking Medication Help People Stop Vaping?

Researchers at Yale University and the Medical University of South Carolina are conducting the Vaping Cessation (VIVA) study to learn whether varenicline, an FDA-approved medication for cigarette smoking, can also help people stop or reduce nicotine vaping. In addition to studying whether varenicline supports vaping cessation, researchers will examine potential health changes that come from reducing or quitting vaping altogether.

The study involves both virtual and in-person visits over 12 weeks, with one follow-up virtual visit at week 26. Participants may receive up to $492 for completing all study activities, including daily diaries and video uploads. By taking part, you may gain support in quitting vaping while also contributing to important research that could help others in the future.

Study Background

Can a Quit-Smoking Medication Help People Stop Vaping?

Researchers at Yale University and the Medical University of South Carolina are conducting the Vaping Cessation (VIVA) study to learn whether varenicline, an FDA-approved medication for cigarette smoking, can also help people stop or reduce nicotine vaping. In addition to studying whether varenicline supports vaping cessation, researchers will examine potential health changes that come from reducing or quitting vaping altogether.

The study involves both virtual and in-person visits over 12 weeks, with one follow-up virtual visit at week 26. Participants may receive up to $492 for completing all study activities, including daily diaries and video uploads. By taking part, you may gain support in quitting vaping while also contributing to important research that could help others in the future.

Additional Information

This study is being done to find out if varenicline, a medication already approved to help people quit smoking, can also help people stop or reduce vaping, and to understand how reducing or quitting vaping may affect health.

You may be eligible for this study if you meet the following criteria.

Inclusion Criteria:

  • Currently vape or use e-cigarettes with nicotine
  • Willing to quit vaping
  • Ages 18+
  • Live in Connecticut or South Carolina
  • Have access to a smartphone, tablet, or computer for study activities


Exclusion Criteria:

  • Currently pregnant or breastfeeding
  • Screening and Enrollment – You will first go through the consent process and answer questions to see if the study is a good fit for you.
  • Study Medication – If eligible, you may be given varenicline to take as directed during the study.
  • Study Visits – You will take part in both virtual and in-person visits over a 12-week period.
  • Daily Activities – Each day, you’ll complete a short diary and upload two brief videos to track your progress.
  • Follow-Up – At week 26, you will have one final virtual visit to check in on your progress.

You can earn up to $492 for completing all study activities, including bonuses for consistent diary and video completion.

There is no cost for you to participate in our research study.

HIC# 2000038513